Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lung Transplantation | 133 | 2024 | 1310 | 19.090 |
Why?
|
Cystic Fibrosis | 50 | 2024 | 1285 | 6.840 |
Why?
|
Bronchiolitis Obliterans | 15 | 2020 | 213 | 3.590 |
Why?
|
Heart-Lung Transplantation | 16 | 2022 | 87 | 3.580 |
Why?
|
Photopheresis | 7 | 2024 | 35 | 3.520 |
Why?
|
Primary Graft Dysfunction | 7 | 2018 | 111 | 3.070 |
Why?
|
Lung Diseases | 22 | 2020 | 1909 | 2.700 |
Why?
|
Organ Transplantation | 12 | 2024 | 1157 | 2.160 |
Why?
|
Waiting Lists | 13 | 2023 | 765 | 1.930 |
Why?
|
Graft Rejection | 41 | 2024 | 4445 | 1.850 |
Why?
|
Switzerland | 27 | 2022 | 324 | 1.840 |
Why?
|
Tissue and Organ Procurement | 10 | 2023 | 961 | 1.510 |
Why?
|
Tissue Donors | 27 | 2023 | 2331 | 1.350 |
Why?
|
Registries | 25 | 2024 | 8224 | 1.330 |
Why?
|
Heart Transplantation | 17 | 2022 | 3233 | 1.280 |
Why?
|
Hypertension, Pulmonary | 7 | 2018 | 1578 | 0.880 |
Why?
|
Transplantation | 8 | 2013 | 219 | 0.850 |
Why?
|
Postoperative Complications | 20 | 2019 | 15631 | 0.750 |
Why?
|
Immunosuppressive Agents | 23 | 2024 | 4174 | 0.740 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 4 | 2024 | 450 | 0.720 |
Why?
|
Child | 59 | 2024 | 80153 | 0.720 |
Why?
|
Hyperammonemia | 1 | 2020 | 76 | 0.670 |
Why?
|
Quality of Life | 15 | 2024 | 13367 | 0.630 |
Why?
|
Lung | 21 | 2022 | 10000 | 0.610 |
Why?
|
Oseltamivir | 2 | 2019 | 75 | 0.610 |
Why?
|
Scedosporium | 1 | 2017 | 10 | 0.600 |
Why?
|
Lymphoproliferative Disorders | 2 | 2016 | 531 | 0.590 |
Why?
|
Benzodioxoles | 1 | 2018 | 75 | 0.580 |
Why?
|
Adolescent | 58 | 2024 | 88319 | 0.570 |
Why?
|
Aminophenols | 1 | 2018 | 87 | 0.570 |
Why?
|
Mycoses | 2 | 2017 | 386 | 0.570 |
Why?
|
Communicable Disease Control | 2 | 2020 | 846 | 0.560 |
Why?
|
Lymphatic Irradiation | 1 | 2017 | 115 | 0.560 |
Why?
|
Humans | 175 | 2024 | 761504 | 0.550 |
Why?
|
Retrospective Studies | 56 | 2024 | 80636 | 0.540 |
Why?
|
Exercise | 4 | 2021 | 5890 | 0.540 |
Why?
|
Gram-Negative Bacterial Infections | 2 | 2016 | 238 | 0.540 |
Why?
|
Immunomodulation | 1 | 2020 | 549 | 0.540 |
Why?
|
Graft Survival | 16 | 2024 | 3819 | 0.530 |
Why?
|
Child, Preschool | 27 | 2024 | 42230 | 0.520 |
Why?
|
Respiratory Insufficiency | 4 | 2020 | 1230 | 0.510 |
Why?
|
Antibodies | 1 | 2024 | 2418 | 0.510 |
Why?
|
Spiroplasma | 1 | 2015 | 12 | 0.510 |
Why?
|
Exercise Test | 7 | 2024 | 2127 | 0.490 |
Why?
|
International Agencies | 4 | 2015 | 243 | 0.480 |
Why?
|
Kaplan-Meier Estimate | 23 | 2019 | 6484 | 0.470 |
Why?
|
Quinolones | 1 | 2018 | 378 | 0.470 |
Why?
|
Lung Diseases, Interstitial | 3 | 2018 | 918 | 0.470 |
Why?
|
Forced Expiratory Volume | 10 | 2018 | 1814 | 0.460 |
Why?
|
Infant | 24 | 2024 | 36192 | 0.460 |
Why?
|
Aminopyridines | 1 | 2018 | 573 | 0.450 |
Why?
|
Adult | 82 | 2024 | 221177 | 0.450 |
Why?
|
Idiopathic Pulmonary Fibrosis | 3 | 2017 | 515 | 0.450 |
Why?
|
Bronchoalveolar Lavage Fluid | 6 | 2019 | 755 | 0.440 |
Why?
|
Survival Rate | 18 | 2022 | 12725 | 0.440 |
Why?
|
Hepatitis | 1 | 2015 | 228 | 0.430 |
Why?
|
Bronchiectasis | 1 | 2014 | 139 | 0.420 |
Why?
|
Extracorporeal Membrane Oxygenation | 5 | 2016 | 1462 | 0.420 |
Why?
|
Young Adult | 42 | 2024 | 59243 | 0.420 |
Why?
|
Brain Death | 4 | 2022 | 357 | 0.410 |
Why?
|
Preoperative Care | 2 | 2015 | 2242 | 0.410 |
Why?
|
Female | 100 | 2024 | 392644 | 0.410 |
Why?
|
Transplantation Immunology | 2 | 2017 | 532 | 0.410 |
Why?
|
Influenza, Human | 4 | 2020 | 1521 | 0.410 |
Why?
|
Male | 95 | 2024 | 360804 | 0.400 |
Why?
|
Heart Diseases | 6 | 2017 | 2781 | 0.400 |
Why?
|
Respiratory Tract Infections | 5 | 2020 | 1010 | 0.390 |
Why?
|
Societies, Medical | 10 | 2016 | 3905 | 0.390 |
Why?
|
Donor Selection | 3 | 2018 | 232 | 0.390 |
Why?
|
Pandemics | 6 | 2024 | 8654 | 0.370 |
Why?
|
Treatment Outcome | 35 | 2024 | 64680 | 0.360 |
Why?
|
Anti-Bacterial Agents | 10 | 2018 | 7407 | 0.360 |
Why?
|
Immunocompromised Host | 2 | 2017 | 856 | 0.360 |
Why?
|
Breathing Exercises | 1 | 2010 | 59 | 0.350 |
Why?
|
Europe | 7 | 2020 | 3422 | 0.340 |
Why?
|
Respiratory Muscles | 1 | 2010 | 142 | 0.340 |
Why?
|
Transplantation, Homologous | 9 | 2022 | 4806 | 0.340 |
Why?
|
Lymphangiosarcoma | 1 | 2009 | 14 | 0.330 |
Why?
|
Antiviral Agents | 4 | 2019 | 3060 | 0.320 |
Why?
|
Thinness | 1 | 2012 | 490 | 0.320 |
Why?
|
Clarithromycin | 1 | 2009 | 86 | 0.320 |
Why?
|
Severity of Illness Index | 10 | 2020 | 15842 | 0.320 |
Why?
|
Healthcare Disparities | 1 | 2024 | 3358 | 0.310 |
Why?
|
Dyslipidemias | 1 | 2015 | 868 | 0.300 |
Why?
|
Exhalation | 3 | 2018 | 181 | 0.300 |
Why?
|
Pulmonary Diffusing Capacity | 2 | 2018 | 94 | 0.300 |
Why?
|
Consensus | 4 | 2020 | 3123 | 0.290 |
Why?
|
Antifungal Agents | 3 | 2017 | 752 | 0.280 |
Why?
|
Age Factors | 15 | 2020 | 18395 | 0.280 |
Why?
|
Postoperative Care | 3 | 2013 | 1468 | 0.270 |
Why?
|
Standard of Care | 2 | 2020 | 551 | 0.270 |
Why?
|
Patient Selection | 7 | 2016 | 4244 | 0.270 |
Why?
|
Infection Control | 2 | 2017 | 981 | 0.260 |
Why?
|
Ceftazidime | 1 | 2006 | 57 | 0.260 |
Why?
|
Middle Aged | 57 | 2021 | 220895 | 0.260 |
Why?
|
Airway Remodeling | 2 | 2017 | 133 | 0.260 |
Why?
|
Respiratory Therapy | 2 | 2018 | 125 | 0.260 |
Why?
|
Prognosis | 13 | 2024 | 29625 | 0.260 |
Why?
|
Sputum | 2 | 2018 | 506 | 0.250 |
Why?
|
Airway Management | 2 | 2020 | 312 | 0.250 |
Why?
|
Bronchoalveolar Lavage | 3 | 2020 | 128 | 0.250 |
Why?
|
Bacterial Infections | 2 | 2014 | 1390 | 0.250 |
Why?
|
Lung Diseases, Fungal | 2 | 2017 | 126 | 0.250 |
Why?
|
Vaccination | 3 | 2022 | 3384 | 0.250 |
Why?
|
Gentamicins | 1 | 2006 | 243 | 0.240 |
Why?
|
Follow-Up Studies | 18 | 2024 | 39106 | 0.240 |
Why?
|
Lipids | 1 | 2015 | 3341 | 0.240 |
Why?
|
Risk Factors | 31 | 2019 | 74206 | 0.230 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2017 | 4026 | 0.230 |
Why?
|
Immune Tolerance | 2 | 2012 | 2303 | 0.230 |
Why?
|
Breath Tests | 2 | 2018 | 299 | 0.210 |
Why?
|
Coronary Angiography | 1 | 2015 | 4471 | 0.210 |
Why?
|
Canada | 2 | 2024 | 2122 | 0.210 |
Why?
|
Bronchoscopy | 2 | 2019 | 909 | 0.200 |
Why?
|
Reoperation | 9 | 2018 | 4303 | 0.200 |
Why?
|
Respiratory Function Tests | 7 | 2018 | 1682 | 0.200 |
Why?
|
Seasons | 3 | 2020 | 1520 | 0.200 |
Why?
|
Viral Load | 2 | 2014 | 3332 | 0.190 |
Why?
|
Pulmonary Alveoli | 2 | 2017 | 652 | 0.190 |
Why?
|
Nitric Oxide | 3 | 2017 | 2135 | 0.170 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2024 | 1435 | 0.170 |
Why?
|
Diatrizoate Meglumine | 1 | 2019 | 79 | 0.170 |
Why?
|
Body Mass Index | 4 | 2019 | 12953 | 0.160 |
Why?
|
Postoperative Period | 3 | 2020 | 1813 | 0.160 |
Why?
|
Survival Analysis | 9 | 2017 | 10090 | 0.160 |
Why?
|
Lung Neoplasms | 2 | 2017 | 13380 | 0.160 |
Why?
|
Delayed Graft Function | 1 | 2019 | 53 | 0.160 |
Why?
|
Ventricular Function | 1 | 2020 | 406 | 0.160 |
Why?
|
Chest Wall Oscillation | 1 | 2018 | 15 | 0.160 |
Why?
|
Time Factors | 14 | 2019 | 39967 | 0.160 |
Why?
|
Multivariate Analysis | 8 | 2019 | 12059 | 0.150 |
Why?
|
Exercise Tolerance | 3 | 2019 | 836 | 0.150 |
Why?
|
Exocrine Pancreatic Insufficiency | 1 | 2019 | 86 | 0.150 |
Why?
|
Risk Assessment | 6 | 2020 | 23995 | 0.150 |
Why?
|
Mycetoma | 1 | 2017 | 18 | 0.150 |
Why?
|
Gastroesophageal Reflux | 1 | 2005 | 819 | 0.150 |
Why?
|
DNA Virus Infections | 1 | 2017 | 15 | 0.140 |
Why?
|
RNA Virus Infections | 1 | 2017 | 19 | 0.140 |
Why?
|
Proportional Hazards Models | 10 | 2018 | 12463 | 0.140 |
Why?
|
United States | 7 | 2024 | 72334 | 0.140 |
Why?
|
Research Report | 4 | 2012 | 367 | 0.140 |
Why?
|
Virus Shedding | 2 | 2016 | 111 | 0.140 |
Why?
|
Comorbidity | 5 | 2020 | 10508 | 0.140 |
Why?
|
Forecasting | 2 | 2021 | 2928 | 0.140 |
Why?
|
Hyperthyroidism | 1 | 2019 | 294 | 0.140 |
Why?
|
Ribavirin | 2 | 2016 | 395 | 0.140 |
Why?
|
Employment | 2 | 2020 | 1118 | 0.140 |
Why?
|
Esophageal Fistula | 1 | 2017 | 60 | 0.140 |
Why?
|
Patient Care Management | 1 | 2020 | 302 | 0.140 |
Why?
|
Stenotrophomonas maltophilia | 1 | 2016 | 18 | 0.140 |
Why?
|
Biopsy | 3 | 2019 | 6766 | 0.140 |
Why?
|
Metapneumovirus | 1 | 2016 | 28 | 0.140 |
Why?
|
Computer Systems | 1 | 2018 | 470 | 0.140 |
Why?
|
Peanut Hypersensitivity | 1 | 2019 | 219 | 0.130 |
Why?
|
Home Care Services, Hospital-Based | 1 | 2016 | 45 | 0.130 |
Why?
|
Health Status Indicators | 2 | 2019 | 970 | 0.130 |
Why?
|
Echocardiography | 2 | 2020 | 4989 | 0.130 |
Why?
|
Paramyxoviridae Infections | 1 | 2016 | 57 | 0.130 |
Why?
|
Sigmoid Diseases | 1 | 2016 | 59 | 0.130 |
Why?
|
Assisted Circulation | 1 | 2016 | 100 | 0.130 |
Why?
|
Drug Resistance, Microbial | 1 | 2019 | 825 | 0.130 |
Why?
|
Toes | 1 | 2017 | 209 | 0.130 |
Why?
|
Fatal Outcome | 2 | 2017 | 1834 | 0.130 |
Why?
|
Anthropometry | 2 | 2010 | 1349 | 0.120 |
Why?
|
Recurrence | 3 | 2020 | 8465 | 0.120 |
Why?
|
Annual Reports as Topic | 2 | 2011 | 36 | 0.120 |
Why?
|
Fistula | 1 | 2017 | 212 | 0.120 |
Why?
|
Metagenomics | 2 | 2017 | 467 | 0.120 |
Why?
|
Radionuclide Imaging | 2 | 2019 | 1972 | 0.120 |
Why?
|
Coronary Artery Disease | 1 | 2015 | 6403 | 0.120 |
Why?
|
Diverticulitis, Colonic | 1 | 2016 | 138 | 0.120 |
Why?
|
Drainage, Postural | 1 | 2014 | 2 | 0.120 |
Why?
|
Aged | 29 | 2022 | 169289 | 0.120 |
Why?
|
Enterovirus | 1 | 2015 | 67 | 0.120 |
Why?
|
Enterovirus Infections | 1 | 2015 | 74 | 0.120 |
Why?
|
Osteoporosis | 2 | 2019 | 1606 | 0.120 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2008 | 2243 | 0.120 |
Why?
|
Motivation | 2 | 2021 | 2006 | 0.120 |
Why?
|
Cohort Studies | 9 | 2022 | 41487 | 0.120 |
Why?
|
Constipation | 1 | 2019 | 563 | 0.120 |
Why?
|
Exercise Therapy | 2 | 2018 | 929 | 0.110 |
Why?
|
Prevalence | 7 | 2016 | 15732 | 0.110 |
Why?
|
Metagenome | 1 | 2017 | 450 | 0.110 |
Why?
|
Hospitals, University | 1 | 2015 | 563 | 0.110 |
Why?
|
Pneumonia, Bacterial | 1 | 2016 | 316 | 0.110 |
Why?
|
Disease Progression | 4 | 2020 | 13506 | 0.110 |
Why?
|
Fluoroquinolones | 1 | 2015 | 307 | 0.110 |
Why?
|
Acute Kidney Injury | 1 | 2006 | 1924 | 0.110 |
Why?
|
Cytokines | 2 | 2019 | 7396 | 0.110 |
Why?
|
Tobacco Use Disorder | 1 | 2019 | 703 | 0.110 |
Why?
|
Immunologic Factors | 2 | 2014 | 1589 | 0.110 |
Why?
|
Respiratory System | 1 | 2016 | 563 | 0.110 |
Why?
|
Cause of Death | 4 | 2011 | 3683 | 0.110 |
Why?
|
Homozygote | 1 | 2018 | 1776 | 0.110 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2021 | 992 | 0.110 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 3 | 2018 | 3204 | 0.100 |
Why?
|
Syndrome | 2 | 2017 | 3267 | 0.100 |
Why?
|
Incidence | 7 | 2018 | 21353 | 0.100 |
Why?
|
HLA Antigens | 1 | 2018 | 1328 | 0.100 |
Why?
|
Pericardium | 1 | 2017 | 675 | 0.100 |
Why?
|
Emphysema | 1 | 2015 | 238 | 0.100 |
Why?
|
Respiratory Tract Diseases | 1 | 2018 | 750 | 0.100 |
Why?
|
Pneumonectomy | 2 | 2017 | 1119 | 0.100 |
Why?
|
Mycophenolic Acid | 1 | 2014 | 348 | 0.100 |
Why?
|
International Cooperation | 2 | 2016 | 1422 | 0.100 |
Why?
|
Stress, Psychological | 2 | 2019 | 4481 | 0.100 |
Why?
|
Leg | 1 | 2017 | 1088 | 0.100 |
Why?
|
Drug Combinations | 1 | 2018 | 2048 | 0.100 |
Why?
|
Practice Guidelines as Topic | 2 | 2012 | 7390 | 0.100 |
Why?
|
Age Distribution | 3 | 2011 | 2880 | 0.100 |
Why?
|
Photosensitivity Disorders | 1 | 2011 | 80 | 0.090 |
Why?
|
Organ Size | 3 | 2013 | 2254 | 0.090 |
Why?
|
Hypolipidemic Agents | 1 | 2015 | 609 | 0.090 |
Why?
|
Intracranial Hemorrhages | 1 | 2017 | 822 | 0.090 |
Why?
|
Liver | 2 | 2017 | 7529 | 0.090 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2015 | 1039 | 0.090 |
Why?
|
Physical Therapy Modalities | 1 | 2014 | 532 | 0.090 |
Why?
|
Treatment Failure | 1 | 2017 | 2645 | 0.090 |
Why?
|
Forced Expiratory Flow Rates | 1 | 2010 | 75 | 0.090 |
Why?
|
Algorithms | 2 | 2024 | 14031 | 0.090 |
Why?
|
Cryopreservation | 1 | 2016 | 728 | 0.090 |
Why?
|
Spirometry | 3 | 2018 | 929 | 0.090 |
Why?
|
Pseudomonas Infections | 2 | 2012 | 622 | 0.090 |
Why?
|
B-Lymphocytes | 1 | 2024 | 4758 | 0.090 |
Why?
|
Influenza A virus | 1 | 2014 | 458 | 0.090 |
Why?
|
Shock, Septic | 1 | 2017 | 768 | 0.090 |
Why?
|
Decision Support Techniques | 2 | 2017 | 1998 | 0.090 |
Why?
|
Hydrocephalus | 1 | 2017 | 764 | 0.090 |
Why?
|
Anti-Infective Agents | 3 | 2013 | 983 | 0.090 |
Why?
|
DNA, Bacterial | 1 | 2015 | 1479 | 0.090 |
Why?
|
Paranasal Sinuses | 1 | 2012 | 265 | 0.080 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 26125 | 0.080 |
Why?
|
Chi-Square Distribution | 1 | 2015 | 3416 | 0.080 |
Why?
|
Respiration, Artificial | 1 | 2020 | 2628 | 0.080 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2016 | 612 | 0.080 |
Why?
|
Ciprofloxacin | 1 | 2011 | 312 | 0.080 |
Why?
|
Stem Cell Transplantation | 1 | 2018 | 1600 | 0.080 |
Why?
|
Critical Care | 2 | 2020 | 2696 | 0.080 |
Why?
|
Pediatrics | 2 | 2014 | 3589 | 0.080 |
Why?
|
Polymerase Chain Reaction | 2 | 2016 | 6075 | 0.080 |
Why?
|
Intensive Care Units | 2 | 2020 | 3745 | 0.080 |
Why?
|
Antibiotic Prophylaxis | 1 | 2014 | 636 | 0.080 |
Why?
|
Cytomegalovirus Infections | 1 | 2015 | 831 | 0.080 |
Why?
|
Tomography, X-Ray Computed | 3 | 2018 | 20570 | 0.080 |
Why?
|
Sex Factors | 2 | 2020 | 10552 | 0.080 |
Why?
|
Heart Ventricles | 1 | 2020 | 3807 | 0.080 |
Why?
|
Vitamin K Deficiency | 1 | 2008 | 24 | 0.080 |
Why?
|
Rodentia | 1 | 2009 | 262 | 0.080 |
Why?
|
Ischemia | 1 | 2017 | 1882 | 0.080 |
Why?
|
Reference Values | 3 | 2011 | 4920 | 0.070 |
Why?
|
Tissue Adhesions | 1 | 2009 | 218 | 0.070 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2015 | 954 | 0.070 |
Why?
|
Cross-Over Studies | 3 | 2018 | 2078 | 0.070 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2012 | 366 | 0.070 |
Why?
|
Smoking Cessation | 1 | 2019 | 2056 | 0.070 |
Why?
|
Osteocalcin | 1 | 2008 | 274 | 0.070 |
Why?
|
Intestine, Small | 1 | 2013 | 1206 | 0.070 |
Why?
|
Affective Symptoms | 1 | 2010 | 417 | 0.070 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2011 | 445 | 0.070 |
Why?
|
Sirolimus | 1 | 2014 | 1533 | 0.070 |
Why?
|
Death | 2 | 2022 | 676 | 0.070 |
Why?
|
Living Donors | 1 | 2011 | 641 | 0.070 |
Why?
|
Disease Management | 1 | 2017 | 2508 | 0.070 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2017 | 3639 | 0.070 |
Why?
|
Oxygen | 1 | 2018 | 4227 | 0.070 |
Why?
|
Bacteria | 1 | 2017 | 2199 | 0.070 |
Why?
|
Guideline Adherence | 1 | 2016 | 2220 | 0.070 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2010 | 664 | 0.060 |
Why?
|
Communication | 1 | 2020 | 3873 | 0.060 |
Why?
|
Bone Marrow | 1 | 2016 | 2911 | 0.060 |
Why?
|
Bronchi | 1 | 2009 | 845 | 0.060 |
Why?
|
Adrenal Cortex Hormones | 1 | 2014 | 1880 | 0.060 |
Why?
|
Diabetes Mellitus | 2 | 2015 | 5840 | 0.060 |
Why?
|
Kidney Failure, Chronic | 1 | 2017 | 2471 | 0.060 |
Why?
|
London | 1 | 2005 | 234 | 0.060 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2020 | 4016 | 0.060 |
Why?
|
Tacrolimus | 1 | 2008 | 733 | 0.060 |
Why?
|
Logistic Models | 2 | 2019 | 13255 | 0.060 |
Why?
|
Bone Marrow Transplantation | 1 | 2012 | 2693 | 0.060 |
Why?
|
Peritoneal Dialysis | 1 | 2006 | 159 | 0.060 |
Why?
|
Fundoplication | 1 | 2005 | 144 | 0.060 |
Why?
|
Resource Allocation | 2 | 2018 | 350 | 0.060 |
Why?
|
Lymph Nodes | 1 | 2016 | 3466 | 0.060 |
Why?
|
Acute Disease | 2 | 2016 | 7237 | 0.060 |
Why?
|
Gastrointestinal Diseases | 1 | 2012 | 1200 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 3688 | 0.060 |
Why?
|
Influenza Vaccines | 1 | 2011 | 768 | 0.050 |
Why?
|
Mood Disorders | 1 | 2010 | 1127 | 0.050 |
Why?
|
Anxiety | 1 | 2018 | 4573 | 0.050 |
Why?
|
Odds Ratio | 1 | 2015 | 9646 | 0.050 |
Why?
|
Hospitals | 1 | 2017 | 3882 | 0.050 |
Why?
|
Immunohistochemistry | 1 | 2017 | 11076 | 0.050 |
Why?
|
Genotype | 1 | 2018 | 12990 | 0.050 |
Why?
|
Models, Animal | 1 | 2009 | 2112 | 0.050 |
Why?
|
Drug Therapy, Combination | 2 | 2014 | 6310 | 0.050 |
Why?
|
Creatinine | 1 | 2008 | 1899 | 0.050 |
Why?
|
Isoantibodies | 2 | 2017 | 674 | 0.050 |
Why?
|
Prospective Studies | 5 | 2020 | 54425 | 0.050 |
Why?
|
Air Pollution | 1 | 2017 | 2359 | 0.050 |
Why?
|
Kidney Transplantation | 1 | 2017 | 4234 | 0.050 |
Why?
|
Combined Modality Therapy | 1 | 2014 | 8529 | 0.050 |
Why?
|
Cytomegalovirus | 2 | 2018 | 756 | 0.050 |
Why?
|
Kidney | 1 | 2017 | 7048 | 0.050 |
Why?
|
Intraoperative Complications | 1 | 2009 | 1165 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 2 | 2020 | 36426 | 0.050 |
Why?
|
Environmental Exposure | 1 | 2017 | 4486 | 0.050 |
Why?
|
Insulin | 1 | 2016 | 6596 | 0.050 |
Why?
|
Data Interpretation, Statistical | 2 | 2008 | 2691 | 0.050 |
Why?
|
Referral and Consultation | 1 | 2014 | 3600 | 0.050 |
Why?
|
Drug Administration Schedule | 1 | 2009 | 4853 | 0.050 |
Why?
|
Body Composition | 1 | 2010 | 2426 | 0.050 |
Why?
|
Reproducibility of Results | 4 | 2019 | 20098 | 0.050 |
Why?
|
Bone Density | 2 | 2019 | 3551 | 0.050 |
Why?
|
Hematologic Neoplasms | 1 | 2012 | 1896 | 0.050 |
Why?
|
Radiography | 2 | 2017 | 6965 | 0.050 |
Why?
|
Bone Remodeling | 2 | 2019 | 581 | 0.050 |
Why?
|
Communicable Diseases | 1 | 2009 | 875 | 0.040 |
Why?
|
Predictive Value of Tests | 4 | 2016 | 15266 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2017 | 10209 | 0.040 |
Why?
|
Glomerular Filtration Rate | 1 | 2008 | 2176 | 0.040 |
Why?
|
Herpesvirus 4, Human | 1 | 2005 | 1078 | 0.040 |
Why?
|
Swine | 1 | 2009 | 5915 | 0.040 |
Why?
|
Case-Control Studies | 5 | 2018 | 22176 | 0.040 |
Why?
|
Positron-Emission Tomography | 1 | 2016 | 6485 | 0.040 |
Why?
|
Self Care | 2 | 2016 | 796 | 0.040 |
Why?
|
Observer Variation | 1 | 2005 | 2606 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 12974 | 0.040 |
Why?
|
Vaccines | 1 | 2007 | 844 | 0.040 |
Why?
|
Infusions, Intravenous | 2 | 2016 | 2219 | 0.040 |
Why?
|
Risk | 1 | 2011 | 9610 | 0.040 |
Why?
|
Viscoelastic Substances | 1 | 2018 | 20 | 0.040 |
Why?
|
Thyroid Function Tests | 1 | 2019 | 288 | 0.040 |
Why?
|
Mucociliary Clearance | 1 | 2018 | 80 | 0.040 |
Why?
|
Adenocarcinoma | 1 | 2015 | 6346 | 0.040 |
Why?
|
Parathyroid Hormone | 2 | 2019 | 1803 | 0.040 |
Why?
|
Regression Analysis | 2 | 2018 | 6343 | 0.040 |
Why?
|
Herpesvirus 7, Human | 1 | 2017 | 14 | 0.040 |
Why?
|
Viscosity | 1 | 2018 | 336 | 0.040 |
Why?
|
Pancreatic Neoplasms | 1 | 2015 | 5368 | 0.040 |
Why?
|
Qualitative Research | 2 | 2018 | 3023 | 0.040 |
Why?
|
Torque teno virus | 1 | 2017 | 13 | 0.040 |
Why?
|
Gastrointestinal Motility | 1 | 2019 | 234 | 0.040 |
Why?
|
Parainfluenza Virus 3, Human | 1 | 1997 | 25 | 0.040 |
Why?
|
Respirovirus Infections | 1 | 1997 | 52 | 0.040 |
Why?
|
Models, Biological | 2 | 2010 | 9469 | 0.040 |
Why?
|
Histocompatibility | 1 | 2018 | 317 | 0.030 |
Why?
|
Rheology | 1 | 2018 | 347 | 0.030 |
Why?
|
Roseolovirus Infections | 1 | 2017 | 49 | 0.030 |
Why?
|
Inflammation | 1 | 2016 | 10773 | 0.030 |
Why?
|
Mutation | 2 | 2019 | 30052 | 0.030 |
Why?
|
Histocompatibility Testing | 1 | 2018 | 712 | 0.030 |
Why?
|
Interleukin-8 | 1 | 2019 | 695 | 0.030 |
Why?
|
Colostomy | 1 | 2016 | 105 | 0.030 |
Why?
|
Elasticity | 1 | 2018 | 655 | 0.030 |
Why?
|
Picornaviridae Infections | 1 | 2017 | 95 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 2015 | 5821 | 0.030 |
Why?
|
Ileostomy | 1 | 2016 | 121 | 0.030 |
Why?
|
Macrolides | 1 | 2017 | 205 | 0.030 |
Why?
|
Rhinovirus | 1 | 2017 | 203 | 0.030 |
Why?
|
Intestinal Obstruction | 1 | 2019 | 432 | 0.030 |
Why?
|
Muscle Strength | 1 | 2019 | 624 | 0.030 |
Why?
|
Disease Models, Animal | 2 | 2013 | 18252 | 0.030 |
Why?
|
Respiratory Hypersensitivity | 1 | 1997 | 273 | 0.030 |
Why?
|
Withholding Treatment | 1 | 2019 | 617 | 0.030 |
Why?
|
Heart Defects, Congenital | 1 | 2011 | 4671 | 0.030 |
Why?
|
Acetylcholine | 1 | 1997 | 629 | 0.030 |
Why?
|
Patient Education as Topic | 2 | 2016 | 2319 | 0.030 |
Why?
|
Transplants | 1 | 2017 | 206 | 0.030 |
Why?
|
Intestinal Perforation | 1 | 2016 | 249 | 0.030 |
Why?
|
Fungi | 1 | 2017 | 338 | 0.030 |
Why?
|
Signal Transduction | 1 | 2017 | 23445 | 0.030 |
Why?
|
Carbon Monoxide | 1 | 2017 | 547 | 0.030 |
Why?
|
Limb Salvage | 1 | 2017 | 481 | 0.030 |
Why?
|
Sex Distribution | 1 | 2019 | 2281 | 0.030 |
Why?
|
Rats, Inbred BN | 1 | 2013 | 231 | 0.030 |
Why?
|
Netherlands | 1 | 2018 | 2221 | 0.030 |
Why?
|
Transplantation, Heterotopic | 1 | 2013 | 174 | 0.030 |
Why?
|
Nasopharynx | 1 | 2016 | 401 | 0.030 |
Why?
|
Genome, Viral | 1 | 2017 | 667 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2019 | 2850 | 0.030 |
Why?
|
Immunoglobulin E | 1 | 2019 | 1502 | 0.030 |
Why?
|
Glucose Tolerance Test | 1 | 2016 | 1178 | 0.030 |
Why?
|
Nasal Lavage | 1 | 2012 | 17 | 0.030 |
Why?
|
Muscle Weakness | 1 | 2015 | 412 | 0.030 |
Why?
|
Necrosis | 1 | 2017 | 1611 | 0.030 |
Why?
|
Advance Care Planning | 1 | 2020 | 698 | 0.030 |
Why?
|
Aspergillosis | 1 | 2014 | 242 | 0.030 |
Why?
|
Monitoring, Immunologic | 1 | 2012 | 98 | 0.030 |
Why?
|
Sampling Studies | 1 | 2013 | 615 | 0.020 |
Why?
|
Rats, Inbred Lew | 1 | 2013 | 1157 | 0.020 |
Why?
|
Macrophages | 2 | 2017 | 5769 | 0.020 |
Why?
|
Candidiasis | 1 | 2014 | 365 | 0.020 |
Why?
|
Respiratory Syncytial Viruses | 1 | 2012 | 168 | 0.020 |
Why?
|
Colectomy | 1 | 2016 | 688 | 0.020 |
Why?
|
Perception | 1 | 2018 | 1197 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2016 | 1702 | 0.020 |
Why?
|
Chills | 1 | 2010 | 17 | 0.020 |
Why?
|
Muscle Cramp | 1 | 2010 | 34 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2019 | 3162 | 0.020 |
Why?
|
alpha 1-Antitrypsin Deficiency | 1 | 2011 | 112 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2018 | 14605 | 0.020 |
Why?
|
Heart-Assist Devices | 2 | 2011 | 1287 | 0.020 |
Why?
|
Body Fluid Compartments | 1 | 2010 | 50 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2013 | 1705 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2005 | 14666 | 0.020 |
Why?
|
ROC Curve | 1 | 2018 | 3579 | 0.020 |
Why?
|
Propensity Score | 1 | 2018 | 1913 | 0.020 |
Why?
|
Expectorants | 1 | 2009 | 22 | 0.020 |
Why?
|
Intraoperative Care | 1 | 2013 | 767 | 0.020 |
Why?
|
Microbial Sensitivity Tests | 1 | 2016 | 1937 | 0.020 |
Why?
|
Extracellular Matrix | 1 | 2017 | 1726 | 0.020 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2010 | 274 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2019 | 3208 | 0.020 |
Why?
|
Animals | 5 | 2017 | 168459 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2013 | 2469 | 0.020 |
Why?
|
Cadaver | 1 | 2013 | 1358 | 0.020 |
Why?
|
Drug Resistance, Bacterial | 1 | 2016 | 1048 | 0.020 |
Why?
|
Deoxyribonuclease I | 1 | 2009 | 224 | 0.020 |
Why?
|
Length of Stay | 2 | 2012 | 6425 | 0.020 |
Why?
|
Wakefulness | 1 | 2015 | 1265 | 0.020 |
Why?
|
25-Hydroxyvitamin D 2 | 1 | 2008 | 40 | 0.020 |
Why?
|
Leukocytes | 1 | 2016 | 2026 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2019 | 4352 | 0.020 |
Why?
|
Drug Substitution | 1 | 2010 | 290 | 0.020 |
Why?
|
Virus Replication | 1 | 2015 | 2435 | 0.020 |
Why?
|
Nausea | 1 | 2010 | 679 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2016 | 10766 | 0.020 |
Why?
|
Vomiting | 1 | 2010 | 651 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2014 | 2426 | 0.020 |
Why?
|
Fibroblasts | 1 | 2017 | 4141 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2018 | 3156 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 2012 | 15500 | 0.020 |
Why?
|
Fibrosis | 1 | 2013 | 2049 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4575 | 0.020 |
Why?
|
Physical Endurance | 1 | 2009 | 366 | 0.020 |
Why?
|
Pilot Projects | 1 | 2019 | 8631 | 0.020 |
Why?
|
Pulmonary Emphysema | 1 | 2011 | 684 | 0.020 |
Why?
|
Critical Illness | 1 | 2019 | 2723 | 0.020 |
Why?
|
Blotting, Western | 1 | 2013 | 5035 | 0.020 |
Why?
|
Contrast Media | 1 | 2019 | 5311 | 0.020 |
Why?
|
Emergencies | 1 | 2012 | 1217 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2015 | 6019 | 0.020 |
Why?
|
Peripheral Arterial Disease | 1 | 2017 | 1273 | 0.020 |
Why?
|
Collagen | 1 | 2013 | 2638 | 0.020 |
Why?
|
Vitamin D | 1 | 2019 | 3303 | 0.020 |
Why?
|
Particulate Matter | 1 | 2017 | 2605 | 0.020 |
Why?
|
Palliative Care | 1 | 2020 | 3598 | 0.010 |
Why?
|
Health Care Rationing | 1 | 2008 | 437 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2018 | 4063 | 0.010 |
Why?
|
Hypotension | 1 | 2010 | 879 | 0.010 |
Why?
|
Physical Fitness | 1 | 2009 | 743 | 0.010 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2273 | 0.010 |
Why?
|
Health Status | 1 | 2017 | 4077 | 0.010 |
Why?
|
Patient Acceptance of Health Care | 1 | 2018 | 3205 | 0.010 |
Why?
|
Sepsis | 1 | 2018 | 2585 | 0.010 |
Why?
|
Fever | 1 | 2010 | 1618 | 0.010 |
Why?
|
Air Pollutants | 1 | 2017 | 2896 | 0.010 |
Why?
|
Headache | 1 | 2010 | 1256 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2012 | 6814 | 0.010 |
Why?
|
Absorptiometry, Photon | 1 | 2008 | 1738 | 0.010 |
Why?
|
Pseudomonas aeruginosa | 1 | 2009 | 1277 | 0.010 |
Why?
|
Pneumonia | 1 | 2013 | 2143 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2015 | 4948 | 0.010 |
Why?
|
Graft vs Host Disease | 1 | 2012 | 3029 | 0.010 |
Why?
|
Phenotype | 1 | 2018 | 16591 | 0.010 |
Why?
|
Cardiomyopathies | 1 | 2011 | 1964 | 0.010 |
Why?
|
Recovery of Function | 1 | 2010 | 2979 | 0.010 |
Why?
|
Adipose Tissue | 1 | 2010 | 3312 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2013 | 12795 | 0.010 |
Why?
|
Survivors | 1 | 2009 | 2371 | 0.010 |
Why?
|
Databases, Factual | 1 | 2013 | 7967 | 0.010 |
Why?
|
Rats | 1 | 2013 | 23742 | 0.010 |
Why?
|
Blood Glucose | 1 | 2011 | 6391 | 0.010 |
Why?
|
Bronchial Provocation Tests | 1 | 1997 | 216 | 0.010 |
Why?
|
Capsaicin | 1 | 1997 | 231 | 0.010 |
Why?
|
Airway Resistance | 1 | 1997 | 406 | 0.010 |
Why?
|
Guinea Pigs | 1 | 1997 | 1310 | 0.010 |
Why?
|
Administration, Inhalation | 1 | 1997 | 1157 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2012 | 7879 | 0.010 |
Why?
|
Microscopy | 1 | 1997 | 903 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2014 | 13639 | 0.010 |
Why?
|
Neuropeptides | 1 | 1997 | 944 | 0.010 |
Why?
|
Analysis of Variance | 1 | 1997 | 6228 | 0.000 |
Why?
|